LakeShore Biopharma Co., Ltd (LSB)
USD 1.19
(-4.8%)
USD 1.19
(-4.8%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 100.76 Million CNY | -66.43% |
| 2022 | 300.13 Million CNY | 13.46% |
| 2021 | 264.53 Million CNY | 1705.2% |
| 2020 | 14.65 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 FY | 100.76 Million CNY | -66.43% |
| 2023 Q3 | 17.65 Million USD | -95.18% |
| 2023 Q2 | 366.42 Million CNY | 4.7% |
| 2023 Q1 | 349.96 Million CNY | 16.6% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q4 | 300.13 Million CNY | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -200.664% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -8857.1% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -457933.514% |
| Autolus Therapeutics plc | 47.91 Million USD | -110.309% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -14589.121% |
| Shattuck Labs, Inc. | 3.4 Million USD | -2858.525% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -351.345% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -3011.419% |
| Aptose Biosciences Inc. | 621 Thousand USD | -16126.63% |
| Precision BioSciences, Inc. | 7.72 Million USD | -1204.77% |
| Dyadic International, Inc. | 88.87 Thousand USD | -113287.389% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -277.406% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -72919.836% |
| Nektar Therapeutics | 112.62 Million USD | 10.528% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -973.707% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -101685.225% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -1953.962% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | 22.878% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -1143.274% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -137937.497% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 34.67 Million USD | -190.63% |
| INmune Bio, Inc. | 397 Thousand USD | -25282.21% |
| Opthea Limited | 200.53 Million USD | 49.751% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -102.458% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -576.973% |
| Verastem, Inc. | 40.08 Million USD | -151.378% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -2189.127% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -902.262% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -1435.854% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -1650.953% |
| NextCure, Inc. | 5.94 Million USD | -1593.854% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -111709.699% |
| Organovo Holdings, Inc. | 888 Thousand USD | -11247.677% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 800 Thousand USD | -12495.922% |
| Ovid Therapeutics Inc. | 30 Million USD | -235.891% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -433.302% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -311.564% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -33.114% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -288.958% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -191.606% |
| Senti Biosciences, Inc. | 33.53 Million USD | -200.457% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -37640.589% |
| PureTech Health plc | 18.25 Million USD | -452.15% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -69394.74% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -800.432% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -28.646% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 2.57 Million USD | -3813.296% |
| Beam Therapeutics Inc. | 159.91 Million USD | 36.985% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -41.535% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -335.751% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -8.314% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 40.14 Million USD | -151.015% |
| Mesoblast Limited | 100.48 Million USD | -0.283% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 47.223% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -3.5% |
| MediWound Ltd. | 6.35 Million USD | -1486.888% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -0.168% |
| Fortress Biotech, Inc. | 60.85 Million USD | -65.583% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 70.577% |
| Achilles Therapeutics plc | 1.07 Million USD | -9264.997% |
| Seres Therapeutics, Inc. | 101.54 Million USD | 0.765% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -1152.235% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -77.114% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -1338.301% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -237.93% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 84.374% |
| FibroGen, Inc. | 89.69 Million USD | -12.342% |
| Celcuity Inc. | 37.03 Million USD | -172.084% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2223.435% |
| ContextLogic Inc. | 6 Million USD | -1579.456% |
| GH Research PLC | 631 Thousand USD | -15869.473% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -2551.075% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -272244.251% |
| ImmuCell Corporation | 10.54 Million USD | -856.002% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -4989.261% |
| Amarin Corporation plc | 8.73 Million USD | -1053.341% |
| TG Therapeutics, Inc. | 100.11 Million USD | -0.649% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -1767.1% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -5454.982% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -175.66% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -19390.788% |
| Aptorum Group Limited | 3.05 Million USD | -3194.666% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -229.585% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 87.579% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -31788.409% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | 3.671% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -263062.03% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -2160.372% |
| Ardelyx, Inc. | 51.54 Million USD | -95.486% |
| Ainos, Inc. | 5.92 Million USD | -1601.704% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -369.844% |
| Prothena Corporation plc | 10.72 Million USD | -839.906% |
| HilleVax, Inc. | 25.24 Million USD | -299.174% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -407.619% |
| Celularity Inc. | 26.17 Million USD | -284.946% |
| Rallybio Corporation | 173 Thousand USD | -58147.036% |
| Cue Biopharma, Inc. | 4.2 Million USD | -2298.081% |
| Omeros Corporation | 329.7 Million USD | 69.437% |
| Humacyte, Inc. | 38.6 Million USD | -161.055% |
| Immunocore Holdings plc | 82.64 Million USD | -21.929% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -6147.202% |
| Blueprint Medicines Corporation | 610.96 Million USD | 83.507% |
| IO Biotech, Inc. | 1.83 Million USD | -5379.466% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -6811.342% |
| Summit Therapeutics Inc. | 103.29 Million USD | 2.442% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -5.86% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -106.983% |
| Pulmatrix, Inc. | 8.32 Million USD | -1110.128% |
| Elicio Therapeutics, Inc. | 6 Million USD | -1577.499% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -84.657% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -678.427% |
| Acelyrin, Inc. | 1.19 Million USD | -8339.478% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -4.156% |
| Cytokinetics, Incorporated | 607.37 Million USD | 83.409% |
| Vor Biopharma Inc. | 31.83 Million USD | -216.58% |
| Evogene Ltd. | 10.65 Million USD | -845.906% |
| Replimune Group, Inc. | 71.99 Million USD | -39.974% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -13176.334% |
| PDS Biotechnology Corporation | 19.5 Million USD | -416.592% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -382667.504% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 94.194% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 6.62 Million USD | -1420.329% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -40.46% |
| Atai Life Sciences N.V. | 15.21 Million USD | -562.464% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -39416.617% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -6318.304% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -133.528% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -24437.908% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -7260.655% |
| MiMedx Group, Inc. | 48.09 Million USD | -109.5% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -15096.43% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | 43.411% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 64.545% |
| Mereo BioPharma Group plc | 5.3 Million USD | -1801.271% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -17037.308% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -344.007% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | 38.21 Million USD | -163.685% |
| scPharmaceuticals Inc. | 38.81 Million USD | -159.636% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -1067.776% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Precigen, Inc. | 5.89 Million USD | -1609.37% |
| XOMA Corporation | 118.51 Million USD | 14.977% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -900.768% |
| Incyte Corporation | 29.16 Million USD | -245.543% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -171.764% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -1175.698% |
| Seer, Inc. | 25.96 Million USD | -288.104% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 223 Million USD | 54.814% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -303.651% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -671682.487% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -36122.5% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Novavax, Inc. | 168.01 Million USD | 40.025% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -73899.525% |
| UroGen Pharma Ltd. | 98.55 Million USD | -2.249% |
| Sutro Biopharma, Inc. | 149.11 Million USD | 32.423% |
| Entera Bio Ltd. | 256 Thousand USD | -39262.255% |
| Lisata Therapeutics, Inc. | 137.00 USD | -73552727.007% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -2011.196% |
| Chimerix, Inc. | 125 Thousand USD | -80513.898% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -15595.852% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | 27.141% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 98.027% |
| AnaptysBio, Inc. | 16.03 Million USD | -528.343% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 7000.00 USD | -1439433.9% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -6951.601% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -710.418% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -150512.619% |
| AbCellera Biologics Inc. | 71.22 Million USD | -41.483% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -5338.067% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -2474.75% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -151.416% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -25.06% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -94.198% |
| bluebird bio, Inc. | 224.41 Million USD | 55.099% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 83.01% |
| DBV Technologies S.A. | 4.52 Million USD | -2126.411% |
| Fortress Biotech, Inc. | 60.85 Million USD | -65.583% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -1521.879% |
| CorMedix Inc. | 517.01 Thousand USD | -19390.298% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 73.29% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -2573.584% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -9607.839% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -5768.804% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -10758.553% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -1046.517% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -476.901% |
| Onconetix, Inc. | 118.85 Thousand USD | -84680.344% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -2212.77% |
| Adagene Inc. | 13.54 Million USD | -644.218% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 51.313% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -150650.064% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 80.573% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -55.709% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -489.524% |
| SciSparc Ltd. | 24 Thousand USD | -419764.054% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -22.862% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -2534.441% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -597.118% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 50.065% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 95.699% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -438019.013% |
| 2seventy bio, Inc. | 244.01 Million USD | 58.704% |
| ADMA Biologics, Inc. | 130.59 Million USD | 22.839% |
| Clene Inc. | 7.15 Million USD | -1308.94% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -2884.587% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 59.305% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -9052.35% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -38234.268% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 47.686% |
| Absci Corporation | 4.66 Million USD | -2062.39% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 96.272% |
| Surrozen, Inc. | 882 Thousand USD | -11324.872% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -288.943% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -337.643% |
| Cingulate Inc. | 135.09 Thousand USD | -74487.801% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -225.129% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -110.81% |
| Kronos Bio, Inc. | 25.37 Million USD | -297.05% |
| Innoviva, Inc. | 446.23 Million USD | 77.418% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -477.894% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -67.052% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -9867.75% |
| AlloVir, Inc. | 16.64 Million USD | -505.282% |
| Century Therapeutics, Inc. | 46.65 Million USD | -115.97% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -1350488.031% |
| Kura Oncology, Inc. | 9.33 Million USD | -979.805% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -1387.78% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -21805.951% |
| Heron Therapeutics, Inc. | 173.75 Million USD | 42.005% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -2385.469% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -68473.024% |
| HCW Biologics Inc. | 6.3 Million USD | -1498.387% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -53.242% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -120.531% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 78.713% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -163760.045% |
| Histogen Inc. | 4.38 Million USD | -2198.526% |
| Surrozen, Inc. | 882 Thousand USD | -11324.872% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | 100 Million USD | -0.767% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -3930.711% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -108130.981% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -55.921% |
| Avalo Therapeutics, Inc. | 2 Million USD | -4938.369% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 92.804% |
| Turnstone Biologics Corp. | 1.18 Million USD | -8374.968% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -92347.131% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -22.874% |
| Exelixis, Inc. | 189.94 Million USD | 46.949% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -135.015% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -296.659% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 287.73 Million USD | 64.978% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -5454.982% |
| Arcellx, Inc. | 50.84 Million USD | -98.201% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | 34.393% |
| Insmed Incorporated | 1.19 Billion USD | 91.556% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -6811.342% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -374.467% |
| Moolec Science SA | 99.04 Thousand USD | -101637.953% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -264.822% |
| Geron Corporation | 35.05 Million USD | -187.488% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -16950.317% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -135.031% |
| Royalty Pharma plc | 6.13 Billion USD | 98.358% |
| OmniAb, Inc. | 22.07 Million USD | -356.477% |
| Alector, Inc. | 30.45 Million USD | -230.862% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -6036.868% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -335.318% |
| Humacyte, Inc. | 38.6 Million USD | -161.055% |
| Structure Therapeutics Inc. | 4.01 Million USD | -2411.023% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 76.379% |
| 89bio, Inc. | 24.79 Million USD | -306.402% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 16.87 Million USD | -497.317% |
| Immunic, Inc. | 639 Thousand USD | -15669.542% |
| Veracyte, Inc. | 7.52 Million USD | -1239.101% |
| Genelux Corporation | 1.86 Million USD | -5300.181% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -9664.28% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -76902.188% |
| Immunovant, Inc. | - USD | -Infinity% |
| Vericel Corporation | 81.85 Million USD | -23.103% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 93.827% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -1575.268% |
| XBiotech Inc. | - USD | -Infinity% |
| Agenus Inc. | 137.32 Million USD | 26.621% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -168345.343% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -122.759% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -124.917% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -73993.657% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -22339.973% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -1508.675% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -8255.504% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -20464.77% |
| United Therapeutics Corporation | 300 Million USD | 66.411% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | 39.335% |
| XOMA Corporation | 118.51 Million USD | 14.977% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 117.62 Million USD | 14.334% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -1696.21% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -401.355% |
| uniQure N.V. | 130.06 Million USD | 22.525% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -1137.624% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -66966.025% |
| Windtree Therapeutics, Inc. | 15 Million USD | -571.782% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -71.987% |
| Pluri Inc. | 29.05 Million USD | -246.84% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 72.11 Million USD | -39.724% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -2717.092% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -10.854% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 74.02% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -1696.21% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -21385.581% |
| Nutriband Inc. | 79.82 Thousand USD | -126133.775% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -2147.265% |
| Compugen Ltd. | 719 Thousand USD | -13914.934% |
| Roivant Sciences Ltd. | 477.85 Million USD | 78.913% |
| ProKidney Corp. | 3.61 Million USD | -2691.34% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -153769.158% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -173.542% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -11862.095% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -1889.091% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Biomea Fusion, Inc. | 7.83 Million USD | -1186.94% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -4586.855% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -774.565% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -907.17% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -19.174% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -775.857% |
| Imunon, Inc. | 1.13 Million USD | -8744.729% |
| BioAtla, Inc. | 836 Thousand USD | -11953.514% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -14.06% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -2039.889% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | 13.76 Million USD | -631.949% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | 12.74% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -398.725% |
| Galecto, Inc. | 66 Thousand USD | -152577.838% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -597.118% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 93.279% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -1.266% |
| PolyPid Ltd. | 6.37 Million USD | -1479.674% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -10.237% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 14.64 Million USD | -588.208% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -67078.249% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -73899.525% |
| Instil Bio, Inc. | 81.42 Million USD | -23.752% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -15096.43% |
| OncoCyte Corporation | 2.2 Million USD | -4472.022% |
| Elevation Oncology, Inc. | 30.13 Million USD | -234.364% |
| Purple Biotech Ltd. | 163 Thousand USD | -61720.474% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -3875.044% |
| MacroGenics, Inc. | 30.19 Million USD | -233.711% |
| Verona Pharma plc | 48.37 Million USD | -108.309% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -10700.362% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -993.396% |
| Aditxt, Inc. | 1.04 Million USD | -9572.95% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -282.448% |
| Curis, Inc. | 1.48 Million USD | -6667.453% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -14342.483% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -1679356.217% |
| BeiGene, Ltd. | 197.61 Million USD | 49.009% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -7419.953% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -118449.851% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -2575.003% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -91.362% |
| Adicet Bio, Inc. | 17.7 Million USD | -469.211% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -633.547% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 89.77 Million USD | -12.246% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -354.214% |
| Invivyd, Inc. | 722 Thousand USD | -13856.7% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -107.759% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -3446434.837% |
| Moolec Science SA | 99.04 Thousand USD | -101637.953% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -139.991% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -945.413% |
| Vir Biotechnology, Inc. | 111.67 Million USD | 9.766% |
| Evaxion Biotech A/S | 8.48 Million USD | -1087.07% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -34.491% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -1521.097% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -328.087% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -55881.874% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -11996.924% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -3060.834% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -10665.745% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -649.813% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -111.896% |
| ImmunityBio, Inc. | 836.95 Million USD | 87.96% |
| Korro Bio, Inc. | 31.21 Million USD | -222.807% |
| Kineta, Inc. | 150 Thousand USD | -67078.249% |
| BioVie Inc. | 349.89 Thousand USD | -28699.4% |
| Codexis, Inc. | 12.24 Million USD | -723.061% |
| Celularity Inc. | 26.17 Million USD | -284.946% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -57042.178% |
| Cibus, Inc. | 17.67 Million USD | -470.145% |
| Annexon, Inc. | 29.19 Million USD | -245.212% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -8881.049% |
| Eyenovia, Inc. | 8.95 Million USD | -1024.984% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -53.471% |
| NeurAxis, Inc. | 27.07 Thousand USD | -372133.656% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -9451.41% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -18699.883% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -317357.542% |
| Notable Labs, Ltd. | 1.52 Million USD | -6503.367% |
| IN8bio, Inc. | 3.37 Million USD | -2882.166% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -31687.815% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -102.032% |
| Lumos Pharma, Inc. | 6 Million USD | -1579.456% |
| Liquidia Corporation | 2.36 Million USD | -4162.579% |
| Mustang Bio, Inc. | 1.97 Million USD | -4994.407% |
| Quantum-Si incorporated | 13.73 Million USD | -633.547% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -1349.265% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -993.396% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -272244.251% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -505354.319% |
| Vaxcyte, Inc. | 22.11 Million USD | -355.734% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -949.223% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -914.777% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -501.868% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -77413.364% |
| PepGen Inc. | 17.1 Million USD | -489.283% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -21158.939% |
| Solid Biosciences Inc. | 23.94 Million USD | -320.899% |
| Palisade Bio, Inc. | 90 Thousand USD | -111863.748% |
| Nutriband Inc. | 79.82 Thousand USD | -126133.775% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -2320.633% |
| Belite Bio, Inc | 578 Thousand USD | -17333.802% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -775033.638% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -51841.945% |
| Altimmune, Inc. | 175 Thousand USD | -57481.356% |
| Peak Bio, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -2223.435% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -7175.623% |
| Neurogene Inc. | 13.37 Million USD | -653.514% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 67.115% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -283.686% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | -556.294% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -914.777% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -59880.579% |
| Immunome, Inc. | 1.34 Million USD | -7419.953% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -4217.368% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -9976.737% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -148.759% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -813.404% |
| Athira Pharma, Inc. | 1.21 Million USD | -8179.981% |
| XOMA Corporation | 118.51 Million USD | 14.977% |
| Merus N.V. | 10.48 Million USD | -860.787% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -650.371% |
| Rezolute, Inc. | 1.66 Million USD | -5970.324% |
| Clene Inc. | 7.15 Million USD | -1308.94% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -137282.578% |
| BeyondSpring Inc. | 3.36 Million USD | -2895.463% |
| Synlogic, Inc. | 12.49 Million USD | -706.72% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -208.572% |
| Krystal Biotech, Inc. | 6.62 Million USD | -1422.166% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | 41.044% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -1580.577% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -212619.539% |
| MannKind Corporation | 252.15 Million USD | 60.037% |
| Ikena Oncology, Inc. | 7.18 Million USD | -1303.445% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -50536.871% |
| Gossamer Bio, Inc. | 197.4 Million USD | 48.954% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -19278.341% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 64.182% |
| Mural Oncology plc | 8.91 Million USD | -1030.82% |
| Disc Medicine, Inc. | 1.43 Million USD | -6917.227% |
| Champions Oncology, Inc. | 6.09 Million USD | -1553.822% |
| REGENXBIO Inc. | 82.22 Million USD | -22.555% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -20298.13% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -2172.607% |
| Vaxart, Inc. | 2.62 Million USD | -3741.684% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -36997.155% |
| Cellectis S.A. | 36.24 Million USD | -178.048% |
| Longeveron Inc. | 1.44 Million USD | -6859.073% |
| Repare Therapeutics Inc. | 1.01 Million USD | -9876.968% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 91.102% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -125.083% |
| Revolution Medicines, Inc. | 80.57 Million USD | -25.06% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -3041.128% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -56830.719% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -81824.693% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 86.095% |
| Denali Therapeutics Inc. | 44.98 Million USD | -124.022% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -705.865% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -74487.801% |
| Passage Bio, Inc. | 22.92 Million USD | -339.629% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -1568.61% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -15474.555% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -399.714% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -24630.799% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -8382.102% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -21523.9% |
| OmniAb, Inc. | 22.07 Million USD | -356.477% |
| Anew Medical, Inc. | 1.54 Million USD | -6443.336% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -240.891% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -1015.547% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -224.115% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -2385.469% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -95.448% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -1482.651% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -613.195% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -14895.145% |
| Alumis Inc. Common Stock | 30.86 Million USD | -226.531% |
| Equillium, Inc. | 384 Thousand USD | -26141.503% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -1536.1% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -3227.852% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -509521.064% |
| vTv Therapeutics Inc. | 169 Thousand USD | -59525.664% |
| Bio-Techne Corporation | 319 Million USD | 68.411% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -76.822% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | 43.569% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -554.036% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -713.756% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -1996.263% |
| Nkarta, Inc. | 82.27 Million USD | -22.484% |
| BioCardia, Inc. | 982 Thousand USD | -10161.443% |
| Iterum Therapeutics plc | 18.95 Million USD | -431.586% |